Latest News and Press Releases
Want to stay updated on the latest news?
-
LITTLE ROCK, Ark., April 06, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its first quarter 2026 financial results prior to the opening of...
-
KUALA LUMPUR, Malaysia, April 06, 2026 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced the...
-
James Heckman, CEO and founder of Roundtable. Seattle, WA., April 06, 2026 (GLOBE NEWSWIRE) -- Roundtable (“RTB”) CEO James Heckman detailed the Company’s post-merger capitalization strategy...
-
OAKLAND, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, announced today that its...
-
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
-
Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
-
CHICAGO, April 06, 2026 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today...
-
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in...
-
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
- YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now...
-
NEW YORK and WALTHAM, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies...